The findings demonstrated a positive correlation between LMAN2 expression in BC and the IC50 values of several chemotherapeutic drugs, such as mitomycin, etoposide, doxorubicin, and cisplatin (Figure 5A). The gene discussed is LMAN2; the disease is breast cancer.